Table 2.
1988 | 2001 | 2012 | |||||
---|---|---|---|---|---|---|---|
HIV+ | HIV− | HIV+ | HIV− | HIV+ | HIV− | ||
Age distribution | 0–15 years | 8 | 23 | 0 | 0 | 0 | 0 |
16–24 years | 26 | 21 | 6 | 6 | 6 | 6 | |
25–34 years | 38 | 25 | 39 | 33 | 0 | 0 | |
35–44 years | 11 | 21 | 39 | 39 | 44 | 33 | |
45–54 years | 17 | 11 | 17 | 22 | 22 | 33 | |
55–88 years | 0 | 0 | 0 | 0 | 28 | 28 | |
N | (53) | (53) | [18] | [18] | [18] | [18] | |
Factor use (per year) | 0–25.000 units | 8 | 12 | 0 | 0 | 6 | 6 |
25.001–75.000 units | 10 | 20 | 20 | 19 | 28 | 22 | |
75.001–125.000 units | 22 | 16 | 35 | 38 | 11 | 22 | |
125.001–250.000 units | 46 | 37 | 35 | 33 | 17 | 22 | |
250.001–500.000 units | 8 | 12 | 10 | 5 | 33 | 22 | |
500.001- units | 6 | 2 | 0 | 5 | 6 | 6 | |
N | (49) | (50) | [21] | [20] | [18] | [18] | |
Hepatitis B or C | Never | 46a | 63a | 5 | 5 | 6 | 6 |
Current or previous | 54a | 37a | 95 | 95 | 94 | 94 | |
N | (46) | (46) | [21] | [21] | [18] | [18] | |
Bleeding episodes | No episodes | 6 | 4 | 5 | 0 | 6 | 6 |
1–10 episodes | 34 | 53 | 53 | 50 | 61 | 33 | |
11–25 episodes | 30 | 8 | 26 | 15 | 17 | 39 | |
26–50 episodes | 19 | 21 | 16 | 25 | 11 | 11 | |
51+ episodes | 11 | 15 | 0 | 10 | 6 | 11 | |
N | (53) | (53) | [20] | [19] | [18] | [18] | |
Severity of hemophilia | Severe | – | – | 100 | 100 | 89 | 100 |
Moderate | 0 | 0 | 11 | 0 | |||
N | [21] | [21] | [18] | [18] | |||
Inhibitor (ever) | Never | 77 | 84 | 81 | 90 | 67 | 67 |
Current or previous | 23 | 16 | 19 | 10 | 33 | 33 | |
N | (50) | (52) | [21] | [21] | [18] | [18] | |
Joint mobility | 0 | 13 | 9 | 24 | 14 | 17 | 22 |
1 | 17 | 17 | 10 | 5 | 6 | 22 | |
2 | 25 | 9 | 19 | 24 | 44 | 17 | |
3 | 15 | 21 | 10 | 24 | 17 | 22 | |
4 | 17 | 13 | 38 | 24 | 11 | 11 | |
5 | 12 | 30 | 0 | 10 | 6 | 6 | |
N |
aOnly HBV